Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Highly Endocrine Responsive Operable Breast Cancer × Gonadotropin-Releasing Hormone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 29 Breast Neoplasms 9 Neoplasms 2 Stage II Prostate Adenocarcinoma 1 Salivary Gland Neoplasms 1 Prostatectomy 1 Prostate Cancer Metastatic Disease 1 Ovarian Neoplasms 1 Oligometastatic Prostate Carcinoma 1 Metastatic Castration-resistant Prostate Cancer 1 Highly Endocrine Responsive Operable Breast Cancer 1 Cardiovascular Diseases 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Tablets 1 Letrozole 1 Gonadotropin-Releasing Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03397537 2018-01-17

Neoadjuvant Endocrine Therapy in Breast Cancer

Guangdong Provincial People's Hospital

Phase 2 Completed

Highly Endocrine Responsive Operable Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡